The chemotherapy induced nausea and vomiting treatment market is set to reach US$ 4,568.8 Mn by 2033 from US$ 2,592.3 Mn in 2021 showcasing progressive growth at a compound annual growth rate (CAGR) of 6.5% during the forecast period from 2025 to 2033.
The insomnia treatment drugs market is set to reach US$ 4,332.4 Mn by 2026 from US$ 2,689.6 Mn in 2017 highlighting balanced growth at a compound annual growth rate (CAGR) of 5.5% during the forecast period from 2018 to 2026. As per the research citing of United Nations (UN) by 2033 the geriatric population suffering with insomnia is going to rise by 56%. Insomnia is caused by factors such as stress, addiction, irregular circadian rhythm, chronic pain etc.
The pigmentation disorders treatment market is set to reach US$ 12,313.2 Mn by 2033 from US$ 6,777.4 Mn in 2021 showcasing a steady growth at a compound annual growth rate (CAGR) of 6.9% during the forecast period from 2025 to 2033. The American Association for Pediatric Ophthalmology and Strabismus (AAPOS) claims that 1 in 17,000 people suffer with some form of Albinism.
The anti-infective drugs market is expected to witness a CAGR of 3.8% during the forecast period of 2025 to 2033, driven by various factors. Anti-infective drugs, also known as antimicrobial drugs, are used to treat infectious diseases caused by bacteria, viruses, fungi, and parasites. These drugs play a crucial role in combating infections and reducing morbidity and mortality rates associated with infectious diseases. This analysis provides a brief overview of the anti-infective drugs market, followed by an in-depth examination of the three key drivers and one restraint impacting the market.
The industrial burners market is set to demonstrate promising growth rate during the forecast period from 2018 to 2026, growing from US$ 18.40 Bn in 2017. Industrial burners are among the most crucial components of any industrial application having thermal process-based production line.
The overall online payment gateways market expected to demonstrate robust growth rate during the forecast period from 2020 to 2028, up from US$ 15.83 Bn in 2019. Payment gateways enable convenient payment process for the consumer choosing to pay through credit/debit cards. With e-commerce industry demonstrating rapid growth over the past few years, online payment gateways have emerged as the backbone for e-commerce industry.
The pancreatic fistula treatment market stood at US$ 2,098.16 Mn in 2021 and projected to exhibit compound annual growth rate (CAGR) of 5.7% during the forecast period from 2025 to 2033. The International Study Group for Pancreatic Fistulas (ISGPF), defines post-operative pancreatic fistula as ‘external fistula with a drain output of any measurable volume after post-operative day three with an amylase level greater than three times the upper limit of the normal serum value’.
The overall RFID readers market expected to demonstrate double digit CAGR during the forecast period from 2025 to 2033. RFID technology has emerged among the most revolutionary elements across numerous applications including retail, industrial manufacturing, transportation, supply chain management, healthcare and various others. Due to its ease of use, reliability and greater detection range, RFID technology has witnessed profound penetration across numerous industry verticals, thereby emerging as replacement for barcodes.
The global poultry health market is expected to reach US$ 11,506.3 Mn by 2026, and exhibit steady compound annual growth rate of 7.1% during the forecast period from 2018 to 2026. Good poultry health management is essential for poultry production since culturing a flock with best genetic potential will not grow efficiently if they are diseased or infected.
The Painful Diabetic Neuropathy Drugs Market is forecasted to grow at a CAGR of 7% during the forecast period of 2025 to 2033. Painful diabetic peripheral neuropathy occurs in approximately 25% of patients with diabetes mellitus who have treated in the office sitting&sedentary lifestyle. It typically causes burning pain, paresthesias& numbness in a stocking-glove pattern that progress from the feet & hands.
The drugs by therapeutic area include therapy for oncology, cardiovascular, central nervous system, infectious diseases, respiratory, and others. The therapeutic area represents the specific area of medicine where the drug is intended to be used, based on its mechanism of action and intended clinical use. One of the primary drivers of the drugs by therapeutic area market is the increasing prevalence of diseases worldwide. Chronic diseases such as cancer, cardiovascular diseases, and neurological disorders are a significant burden on healthcare systems globally. There is an urgent need for new and effective therapies to treat these diseases, which has led to the growth of the drugs in the therapeutic area market.
The revenues generated by the drugs in the therapeutic area market have been consistently high over the years. The global pharmaceutical market is expected to reach USD 1.5 trillion by 2023, with oncology being the leading therapeutic area. The increasing demand for new therapies, coupled with advancements in technology and an increasing focus on personalized medicine, is expected to drive the growth of the market in the coming years. One of the emerging trends in the drugs by therapeutic area market is the increasing use of precision medicine. Precision medicine involves tailoring medical treatments to individual patients based on their unique genetic and molecular profiles. The development of precision medicine requires the use of advanced diagnostic tools and drug discovery technologies, which have contributed to the growth of drugs in the therapeutic area market.
Another trend in the drugs by therapeutic area market is the increasing focus on biologics. Biologics are drugs that are produced from living cells and are used to treat a wide range of diseases, including cancer and autoimmune disorders. Biologics are more complex than traditional small-molecule drugs, and their development requires specialized manufacturing processes and clinical trial design. The increasing demand for biologics has contributed to the growth of the drugs by therapeutic area market. The increasing focus on rare diseases is also driving the growth of the drugs by therapeutic area market. Rare diseases are defined as diseases that affect fewer than 200,000 people in the United States. Although each rare disease affects a small number of people, there are over 7,000 rare diseases, which together affect millions of people worldwide. There is an urgent need for new therapies to treat rare diseases, which has led to the growth of drugs in the therapeutic area market.
The increasing use of combination therapies is driving the growth of the drugs by therapeutic area market. Combination therapies involve the use of two or more drugs to treat a disease. Combination therapies can improve patient outcomes by targeting multiple pathways involved in the disease process. The development of combination therapies requires the use of advanced drug discovery technologies and clinical trial design, which has contributed to the growth of the drugs by therapeutic area market. The increasing prevalence of diseases worldwide, advancements in technology, and the emerging trends in precision medicine, biologics, rare diseases, and combination therapies are expected to drive the growth of the drugs by therapeutic area market.
